Compass therapeutics nasdaq: cmpx
WebApr 11, 2024 · Compass Therapeutics, Inc. ( NASDAQ:CMPX – Get Rating) has earned a consensus recommendation of “Buy” from the seven brokerages that are currently … WebApr 11, 2024 · Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Rating) has received an average rating of "Buy" from the seven ratings firms that are currently covering the firm, Marketbeat.com reports.Six analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on the stock in the last year …
Compass therapeutics nasdaq: cmpx
Did you know?
WebGet the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebMar 17, 2024 · Compass Therapeutics Stock Down 3.9 %. Shares of NASDAQ CMPX opened at $3.42 on Friday. Compass Therapeutics has a 52-week low of $1.25 and a 52-week high of $5.65. The stock has a market ...
WebMar 12, 2024 · Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Rating) CEO Thomas J. Schuetz acquired 10,000 shares of the stock in a transaction on Friday, March 10th. The shares were acquired at an average price of $3.37 per share, for a total transaction of $33,700.00. Following the acquisition, the chief executive officer now owns 6,021,873 … WebMay 9, 2024 · With a market capitalization of US$170m, Compass Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups ...
WebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn … WebApr 11, 2024 · Compass Therapeutics Stock Up 2.4 % NASDAQ:CMPX opened at $3.44 on Tuesday. Compass Therapeutics has a 52 week low of $1.30 and a 52 week high of …
WebFind real-time CMPX - Compass Therapeutics Inc. stock quotes, company profile, news and forecasts from CNN Business. ... Compass Therapeutics Inc. (NASDAQ:CMPX) …
WebTrade Alert: The Co-Founder Of Compass Therapeutics, Inc. (NASDAQ:CMPX), Thomas Schuetz, Has Just Spent US$50k Buying A Few More Shares. Whilst it may not be a huge deal, we thought it was good to ... jimmy john\u0027s north hollywoodWebCMPX Stock 12 Months Forecast. $9.20. (192.06% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $9.20 with a high forecast of $11.00 and a low forecast of $8.00. The average price target represents a 192.06% change from the last price of $3.15. jimmy john\u0027s new richmondWebCompass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both … jimmy john\u0027s new braunfels texasWebMar 14, 2024 · See the latest Compass Therapeutics Inc Ordinary Shares stock price (NASDAQ:CMPX), related news, valuation, dividends and more to help you make your … jimmy john\u0027s new sandwichesWebApr 10, 2024 · A high-level overview of Compass Therapeutics, Inc. (CMPX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … jimmy john\u0027s north bendWebApr 1, 2024 · Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,130,000 shares, an increase of 17.7% from the February 28th total of 1,810,000 shares. Approximately 3.2% of the shares of the stock are short … jimmy john\u0027s new hartfordWebMar 30, 2024 · BOSTON, March 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biotechnology company developing proprietary antibody-based therapeutics to ... jimmy john\u0027s north carolina